1Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Mangement of Chronic Heart Failure in the Adult-Summary Article:A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).Circulation,2005,112:1825-1852.
5MERIT-HF Study.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).Lancet,1999,353:2001-2007.
6O' Connell JB.The economic burden of heart failure.Clin Cardiol,2000,23(Suppl):Ⅲ6-10.
7Khand A,Gemmel I,Clark AL,Cleland JGF.Is the prognosis of heart failure improving? J Am Coll Cardiol,2000,36:2284-2286.
8Cleland JG,Clark A.Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure:too many cooks will spoil the broth.J Am Coll Cardiol,2003,42:1234-1237.
9Hochleitner M,Hortnagl H,Ng CK,et al.Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy.Am J Cardiol,1990,66:198-202.
10Innes D,Leitch JW,Fleetcher PJ.VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure.PACE,1994,17:959-965.
二级参考文献67
1Desai AD, Liem LB, Chun SH, et al. Accuracy of the Ritter method in determining optimal atrio-ventricular delay in patients undergoing cardiac resynchronization therapy for congestive heart failure. PACE,2001,24(Part II):665.
2Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation,2000,102:3053-3059.
3Beanlands RS, Bach DS, Raylman R, et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measure using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol,1993,22:1389-1398.
4Hasenfuss G, Holubarsch C, Heiss HW, et al. Myocardial energetics in patients with dilated cardiomyopathy: influence of nitroprusside and enoximone. Circulation,1989,80:51-64.
5Hasenfuss G, Holubarsch C, Heiss HW, et al. Influence of enoximone on myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside. J Cardiovasc Pharmacol,1989,14:S69-S74.
6Eichhorn EJ, Heesch CM, Barnett JH, et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol,1994,24:1310-1320.
7Bardy GH. SCD-HeFT. The sudden cardiac death in heart failure trial. The American College of Cardiology Annual Scientific Session. New Orleans, March 8, 2004.
8Young JB, Abranham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. JAMA,2003,289:2685-2694.
9Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol ,2003,42:1454-1459.
10Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med,2001,344:873-880.
